Transcript Highlights:

• enable those institutions to conduct vital research on hemp varieties, cultivation methods. product development

Bills: HB147, HB 1113, HB 1203, HB 1269, HB 1276, HB 1277, HB1437, HB147

Keywords: livestock, brands, marks, earmarks, tattoos, electronic registry, Texas Animal Health Commission, county clerk, Agriculture Code, cattle, hogs, sheep, goats, horses, animal identification, brand registry, livestock traceability, electronic filing, rerecording, law enforcement access

Transcript Highlights:

• that are often going unfilled are things like special cloud specialists in the cloud, software developers
• in the uh special Cloud specialists in the cloud<00:13:36.079> software<00:13:36.560> developers
• <00:13:37.120> and<00:13:37.279> folks<00:13:37.519> in cloud software developers
• and folks in cloud software developers and folks in AI<00:13:38.279> as<00:13:38.399> we're
• It enables us to secure property transfers, reduces timing costs on development projects, road projects

Bills: HF1, HF1754, HF1809, HF1478

Keywords: Office of Inspector General, inspector general, legislative audit, fraud prevention, waste and abuse, public funds, grant oversight, state grants, grant management, whistleblower protection, retaliation, subpoena power, data practices, government transparency, accountability, law enforcement referrals, sanctions, debarment, payment withholding, public assistance fraud

Transcript Highlights:

• So, we developed another plan. It... work. So, we developed another plan.

Bills: SB60, SB103, SB60, SB103

Keywords: prison modernization, corrections finance, bonding authority, state debt, capital improvement, Department of Corrections, Alabama Corrections Institution Finance Authority, prison construction, prison renovation, prison replacement, bed space, overcrowding, women's prison, men's prison, Escambia prison, Tutwiler, Kilby, Elmore, Staton, St. Clair Correctional Facility

Transcript Highlights:

• rebate if we've already given a 340B price.
• They will always get the rebate first.
• negotiated rebate doesn't happen either.
• You can give more rebates, can't you?
• They could be paid based on a rebate, and so they discount the drug, and then they have a rebate.

Transcript Highlights:

• So this is not a new development, right?
• And then you get back into rebates and spread pricing.
• No spread pricing, no rebates.
• 99% rebate back to the plan sponsor.
• Now, they choose how to use those rebate dollars.

Keywords: 1185, senate, all

Transcript Highlights:

• The complexities of factoring in the drug rebate is compounded by a lack of rebate transparency, extremely
• believe that passing drug rebates believe that passing drug rebates directly<01:35:07.760> onto
• is compounded by a lack the drug rebate is compounded by a lack of<01:35:17.119> rebate of rebate
• also important to note that drug rebates also important to note that drug rebates are<01:35:26.360
• <01:47:32.199> Avail know there are rebates Avail know there are rebates Avail available<01

Keywords: 910, house, all

Summary: The committee first took up SB 1494 on hearing aids. Testimony was generally supportive of expanding hearing-aid coverage, with the Insurance Division raising concern about possible federal defrayment issues, SHPDA supporting the goal of hearing augmentation, DCAB strongly supporting the bill as an important access issue, and health plans and insurers asking for amendments. Kaiser Permanente and the Hawaii Association of Health Plans requested changes to add a medical-necessity standard and clarify annual notice language, while HMSA suggested the proposal should be studied by the auditor. The chair noted concerns about federal preemption and the lack of an audit, and deferred the bill in favor of a related resolution calling for a study. The committee then heard SB 1448, an emergency appropriation for the Hawaii State Hospital. DAGS and the Department of Health supported the measure, with the hospital administrator saying the funding would improve the environment of care, support cleaning, and allow a third-party review of the building. Committee members questioned the size of the request and the status of litigation against the design-builder. Administration witnesses said they were pursuing a comprehensive study involving destructive testing, had made a demand on the design-builder to fund the study, and were using different processes than before. They also said the roof work would be handled through a separate CIP request. No final action was taken in the portion provided. The committee next heard SB 1432, relating to the future responsibilities of the Department of Health and land issues at Kalaupapa after the last patient dies. DOH supported the bill in part but said its long-term role would be limited mainly to environmental cleanup, with operations expected to continue under the National Park Service and land-use decisions left to DHHL and beneficiary consultation. DHHL asked that the measure reflect that any land-use or zoning changes on homeland lands require commission approval and beneficiary consultation. Testifiers from Kalaupapa and Maui County, including Degra Vanderbilt-Papa and Council Member Keani Rollins-Fernandez, supported deferring the bill, saying there had been no meaningful community discussion about provisions affecting Kalaupapa’s future management and possible transfer of responsibilities to Maui County. The committee also read into the record written testimony from Gloria Marks emphasizing that Kalaupapa stakeholders must be included in future discussions. Finally, the committee heard SB 955 on fitness-to-proceed examinations. The Judiciary and the Public Defender’s Office both supported raising pay and standardizing expectations for private examiners, but opposed reducing felony fitness evaluations from three examiners to one and opposed expanding use of expedited reports. They argued that a single examiner would reduce reliability, create a more adversarial process, and likely increase costs and contested hearings, while expedited reports do not contain enough information for a proper fitness determination. The Department of Health also supported the bill’s intent but asked to preserve a three-examiner framework and said the goal was to reduce the number of people sent to the State Hospital, where admissions have reportedly risen about 20% year over year since Act 26. The bill remained under discussion in the excerpt, with no final vote shown.

Transcript Highlights:

• will be, how many rebates will there be, you know, what manufacturers will receive the rebates, or how
• What's going to be the size of the rebates? How many rebates do you anticipate? Yeah.
• It doesn't actually translate into a rebate.
• And this rebate is almost like, hey, keep trying, all right.
• Just as importantly, it prevents costly sprawl development.

Summary: The meeting began with a budget subcommittee hearing on a proposed sustainable aviation fuel (SAF) tax credit trailer bill. Assembly Members Ávila Farías and another member spoke in support, emphasizing union jobs, refinery investments, and the need to decarbonize aviation. The Department of Finance said the Governor’s proposal would provide a $1 to $2 per gallon credit against the diesel excise tax for SAF sold in California from 2026 to 2036. The Legislative Analyst’s Office recommended rejecting the proposal, arguing it is a relatively expensive way to reduce emissions, has uncertain environmental benefits, could significantly reduce transportation revenues, and conflicts with the spirit of voter restrictions on transportation taxes. Committee members questioned whether the credit would mainly benefit out-of-state producers, whether firms would have diesel tax liability to use the credit, and whether the proposal would shift production away from renewable diesel and raise fuel prices. Administration and CARB staff said the credit is intended to support aviation decarbonization, preserve jobs, and help keep California on track toward its 2045 climate goals. LAO and UC Berkeley testimony countered that the policy could mostly subsidize existing technologies, that feedstock supply is limited, and that the net emissions benefit may be small relative to the cost. Members also asked about the effect on local streets and roads, SHOP, and trade corridor funding; Finance estimated a $165 million annual revenue impact would reduce those programs, while LAO said the reductions would mean fewer projects over time. No vote was taken, and the chair said the issue would remain open for further discussion. The committee then moved to a zero-emission vehicle incentive trailer bill proposing a one-time $200 million appropriation to CARB for a new point-of-sale incentive program focused on first-time buyers and leases of new and used light-duty ZEVs. Supporters said the program would help offset the loss of the federal EV tax credit, maintain momentum in California’s ZEV transition, and use a one-to-one match with participating automakers to double the state’s investment. LAO recommended rejection, saying the proposal does not meet the high budget bar this year, lacks enough program detail to evaluate, is unlikely to move sales significantly given the size of the appropriation, and could duplicate existing state and utility programs. Members asked about current incentives across light-, medium-, and heavy-duty sectors, the recent decline in ZEV sales, and whether the program would help lower-income buyers rather than subsidize purchases that would have happened anyway. CARB said the proposal is meant to fill a gap in the light-duty market, where sales fell sharply after the federal credit expired, and noted existing programs for other vehicle classes. The Department of Finance also addressed a separate question about the Motor Vehicle Account, saying a previously planned GGRF transfer was no longer needed because updated forecasts showed the fund had sufficient balances, though LAO said the account still has a structural long-term imbalance. The discussion ended before any vote or action on the ZEV proposal.

Transcript Highlights:

• but in our neighboring states to develop but in our neighboring states to develop the<00:31:52.559
• developed it we did not develop developed it we did not develop participant<01:09:56.719> benefits
• FN relative to rebates to rate payers FN relative to rebates to rate payers from<01:31:41.360> the
• used to support other people developing used to support other people developing renewable<01:45:
• That takes out the challenge of having to develop a mechanism in order to rebate this money back to the

Keywords: 1189, house, all

Transcript Highlights:

• Other developed countries have got it down to 30.
• Other developed countries have got it down to 30.
• This will be in your next staff analysis of our ASR rebates that have gone to plans.
• In our current world, we’re used to the cash coming back because we talk about rebates.
• In our current world, we’re used to the cash coming back because we talk about rebates.

Summary: The committee first heard Senate Bill 1414 by Sen. Polsky on congenital cytomegalovirus (CMV) education. The bill would require the Department of Health, working with medical experts, to create and distribute CMV educational materials to expectant and new parents or caregivers through hospitals, birth centers, and OB/GYN practices. An amendment removed a section that would have required instruction for medical professionals, and the amended bill was reported favorably as a committee substitute. The committee then took up a block of confirmations. Appointees on tabs 2 through 7 were recommended favorably in one vote, and Chavon Harris was separately confirmed as Secretary of the Agency for Health Care Administration after extensive questioning. Senators praised her leadership and experience, while others raised concerns about Medicaid redeterminations, the state’s CORE modernization project, Hope Florida, and a DCF anti-marijuana ad campaign; Harris said she would follow up on some issues and defended the agency’s work on transparency, managed care oversight, and access to care. Her confirmation was recommended favorably, with Sen. Berman noting opposition. Several health-related bills were then heard and advanced. SB 186 by Sen. Garcia expanded epilepsy training requirements for school personnel, including charter school bus drivers, and was reported favorably. SB 902 by Sen. Garcia, after amendments narrowing dental workforce provisions and allowing certain seizure rescue medication delegation to family home health aides, was reported favorably; testimony focused on medical marijuana regulation, practitioner accountability, and concerns about park and child-care proximity restrictions. SB 196 by Sen. Sharif created a uterine fibroid research database with privacy protections and was reported favorably after emotional testimony from a patient and supporters. SB 688 by Sen. Rodriguez would reestablish licensure of naturopathic doctors; it drew both support and skepticism about diagnosis and treatment boundaries, but was reported favorably. SB 1574, Maddie’s Law, would add biliary atresia screening to newborn screening and was strongly supported by parents describing a delayed diagnosis; it was reported favorably. SB 878 on clinical laboratory personnel, SB 1092 on podiatric medicine and certain cellular/tissue-based products, and SB 1032 on medical marijuana registry timelines and veteran fee waivers were also reported favorably, while SB 1032 drew debate over longer renewal/supply periods. The committee then began SB 1760 on Medicaid oversight and program transparency, with the sponsor describing the bill’s creation of a joint legislative oversight committee and a legislative actuary.

Transcript Highlights:

• The rebate certainly helps that. The rebates get spent at businesses here in Minnesota.
• And now we're looking at how we can get into the garbage. there's a rebate that's there's a rebate that's
• Um we also as was they get a rebate.
• commercial development within St. Paul. commercial development within St. Paul.
• crucial tool for economic development crucial tool for economic development and<01:42:53.440>

Keywords: 1187, senate, all

Transcript Highlights:

• The families get a rebate. It families. The families get a rebate.
• first is the home efficiency rebate first is the home efficiency rebate program<00:37:13.040>
• It repeals the rebate. Now, that rebate is at the point of sale.
• It repeals the rebate. Now, that rebate is at the point of sale.
• electrification rebates have served electrification rebates have served 16,000<00:58:27.599>

Keywords: U.S. House of Representatives Floor Proceedings on Wednesday, February 25, 2026, 1012, house, all

Transcript Highlights:

• HB 5169 by Shaheen, relating to the limitations applicable to certain agreements provided by the rebate
• HB 5194 by Capriglione relates to improving the efficiency of the state workforce development programs
• HB 5169 by Shaheen, relating to the limitations applicable to certain agreements provided by the rebate
• , health, civic engagement, and social development.
• development boards and is referred to the Committee on Trade, Workforce, and Economic Development.

Keywords: 1184, house, all

Transcript Highlights:

• present about uh some geothermal rebate present about uh some geothermal rebate program<00:01:57.039
• rebates for geothermal systems.
• rebates for geothermal systems.
• initial path for project development initial path for project development okay<00:10:16.040>
• Woodbury so we're not fully developed Woodbury so we're not fully developed yet<00:10:29.920>

Keywords: 1183, house

Transcript Highlights:

• Northeastern State College in 1965, he worked for Sunray DX Oil Company as a chemist in research and development
• Members, economic development, workforce And tourism will meet immediately following adjournment.

Bills: SB1265, SB1198, SB2046, SB1415, SB1714, SB1962, SB26, SB172, SB260, SB264, SB1525, SB1332, SB1998, SB1378, SB1771, SB1919, SB2018, SB1936, SB1612, SB1543, SB1260, SB1988, SB1859, SB2041, SB1257, SB1726, SB1236, SB1633, SB1413, SB1317, SB1360, SB1342, SB1477, SB1189, SB1546, SB1524, SB1338, SB1193, SB1812, SB1617, SB1638, SB504, SB2072, SB1283, SB1216, SB1655, SB2011, SB1643, SB1446, SB1256, SB1258, SB1441, SB1224, SB1448, SB1496, SB1597, SB1621, SB1827, SB2066, SB2104

Keywords: healthcare authority, property lien, county treasury, local government, Oklahoma, municipalities, campsite regulation, Department of Environmental Quality, unauthorized camps, public safety, environmental standards, nondisclosure agreements, state employment, employee rights, transparency, government accountability, employee suggestions, cost savings, state agencies, incentives

Transcript Highlights:

• Specifically, a broker may exclude the rebate payments it makes to its dealers.
• A dealer may exclude rebate payments.
• I don't know, but are rebate payments currently excluded from taxation?
• The rebate on which he receives his pay is taxable. Thank you.
• Utilities have different programs, different kinds of rebates.

Bills: SB264, SB542, SB924, SB1008, SB1029, SB1036, SB1057, SB1058, SB1185, SB1202, SB1358, SB1364, SB1376, SB1569, SB1664, SB1697, SJR50

Keywords: SB 264, Texas Workers' Compensation Act, group self-insurance, self-insured groups, workers' compensation, Texas Department of Insurance, commissioner of insurance, certificate of approval, guaranty fund, trust fund, wind down, dissolution, labor code, insurance regulation, employer coverage, risk pool, business and commerce, trade workforce economic development, property owners' association, water conservation

Transcript Highlights:

• Florida is a growing state, and our natural resources are constantly being encroached upon by development
• Florida is a growing state, and our natural resources are constantly being encroached upon by development
•   195 AS A COMMUNITY WHEN I WAS ON  THE TOWN COUNCIL AND AS MAYOR WE  196 DEVELOPED WITH
• The rebates manufacturers pay could go directly to the patient at the pharmacy counter to bring down
• I would love the rebates and the discounts to go to our federally qualified healthcare providers.

Summary: The committee first took up CS/House Bill 981, which would restore the Ocklawaha River and related natural resources. Supporters, including environmental groups, Save the Manatee Club, business owners, and Reunite the Rivers advocates, argued the bill would improve manatee habitat, fish passage, flood protection, tourism, and long-term economic returns while reducing dam maintenance costs. Opponents and skeptics focused on concerns about water quality, nutrient loading in the St. Johns River, loss of the Rodman Reservoir’s habitat and water-supply value, and potential ecological and economic harms. Members in debate largely supported the restoration effort, and the bill was reported favorably on a unanimous vote. The committee then heard HB 697, the PRICE Act, which would use international reference pricing to set a drug cost benchmark, address pharmacy benefit manager practices, and require health plans to keep drug prices stable for the year. The sponsor said the bill would lower costs and improve access, especially for uninsured Floridians. Supporters, including independent pharmacists, argued PBMs are squeezing pharmacies and that the bill could help lower prices. Opponents from BioFlorida and PhRMA warned the proposal could disrupt the national drug supply chain, fail to pass savings to patients, and lead to shortages, reduced access, and less innovation. After debate, the bill passed favorably, with Rep. Chambliss voting no. The committee also considered CS/HB 1081, which was amended to include private colleges and universities with NCA designation in the program. After brief discussion and support from United Way Miami, the committee reported the bill favorably. Finally, CS/HB 177 was introduced as a framework for Florida’s regional councils to cross-assign bills among regions; it received supportive testimony and was also reported favorably. The meeting then adjourned.

Transcript Highlights:

• pricing available to covered entities and pharmacies at a discount at the time of purchase, not a rebate
• to be given of purchase not a rebate to be given later.<00:15:23.839> Uh<00:15:24.240> this
• Since we do not own these buildings, they would not be available for potential housing development, and
• <00:24:46.159> The<00:24:46.320> committee de community development.
• The committee de community development.

Keywords: 926, house, all

Summary: The House opened with a devotional by Reverend Kemp Randolph, who reflected on the idea that simpler solutions often require letting go of existing assumptions and urged lawmakers to consider what they may need to give up to achieve the greatest good. After the prayer, the chamber introduced House Bill 889, exempting disability-related income on candidate disclosure forms, and House Bill 890, aimed at reducing barriers for nonprofit religious organizations providing preventive health care services. Both bills were read the first time and referred to committee. The House also referred three bills to money committees under House Rule 35A: H.548 to Appropriations, and H.557 and H.567 to Ways and Means. Members then offered several announcements, including welcoming the guest pastor Kemp Randolph and visiting European Parliament member Maria Walsh, along with her mother and aunt. There were also notices about caucus meetings and a correction to a prior vote explanation regarding H.70. The House then took up H.611, a technical and housekeeping bill affecting the Department of Vermont Health Access. Committee testimony and floor remarks described provisions to reduce administrative burdens, update advisory committee membership, remove outdated references tied to the individual/small group market split, adjust the VARMM prescription drug assistance program, increase the allowable amount in Medicaid-related prepaid funeral arrangements, and delay Medicaid coverage for doula services by one year while federal approval is sought. The Health Care and Appropriations committees both recommended the bill, with Appropriations noting no fiscal impact and correcting a prior vote tally. The House adopted the Health Care Committee amendment to H.611 and ordered the bill to third reading. It then passed H.540, relating to recommendations of the post-adjudication reparative program working group. Finally, the House concurred in the Senate proposal of amendment with further amendment on H.50, concerning identification of underutilized state buildings and land; the committee explained changes restoring annual reporting, removing leased buildings from the inventory, and directing annual reports to the Department of Housing and Community Development through 2030. The chamber concluded with announcements about a Joint Fiscal Committee meeting on a rural health transformation grant and then adjourned until February 10, 2026.

Transcript Highlights:

• That secondary market, because these vehicles are so new, hasn’t really developed.
• So new, hasn’t really developed. This is part of an incentivization of that methodology.
• They currently have a new vehicle rebate program, so it will just attach onto that. Thanks.
• And then if you're bringing a developer to develop a project, then they front the money on their understanding
• The developer. So you need state authorization in order for the developer to make a microgrid?

Keywords: 993, senate, all

Summary: The Senate Standing Committee on Energy and Telecommunications, chaired by Senator Kevin Parker, considered a lengthy agenda of energy- and utility-related bills. The committee discussed measures on utility outage penalties for combination utilities, a NYSERDA-backed electric landscaping rebate program, stronger utility storm response compliance, a study on utility reporting of late payments to credit agencies, a used zero-emission vehicle rebate program, alternative fuels along the New York State Thruway, a property tax exemption for energy-related utility real property, a NYSERDA pilot microgrid at Glenwood Houses, a prohibition on PSC approval of certain utility rate increases, a sustainable aviation fuel tax credit, a usage monitoring program, and a bill on denial of increased utility rates and charges. Several bills prompted questions about who would pay for the programs or penalties, with sponsors and staff repeatedly stating that fines would be paid by utilities and that many programs would be funded through NYSERDA or existing appropriations, though members raised concerns about whether ratepayer funds or system benefits charges could be used. The electric landscaping rebate bill drew extended debate over whether its equipment definitions could allow companies to use battery equipment charged by generators, while the microgrid pilot and used EV rebate bills were defended as investments to improve reliability, lower peak costs, and build a secondary EV market. Senator May spoke in support of the Glenwood Houses microgrid and the related investment rationale. Most bills were advanced after motions and votes, often with some no votes or without-recommendation votes. The committee reported several measures to third reading, including the utility outage penalties bill, the utility storm response bill, the utility rate increase restriction bill, the usage monitoring program, and the denial of increased utility rates and charges bill. Other bills were advanced to the Finance Committee, Budget and Revenue Committee, or Local Government Committee, including the electric landscaping rebate program, the used EV rebate program, the alternative fuels bill, the tax exemption bill, the Glenwood Houses microgrid pilot, and the sustainable aviation fuel tax credit.

Transcript Highlights:

• They were sales tax rebates.
• They were sales tax rebates.
• They were sales tax rebates.
• They were sales tax rebates.
• They were sales tax rebates.

Keywords: 1183, house

Transcript Highlights:

• Manufacturers pay rebates back to the state, but individual drug rebate amounts are confidential.
• In 2025, overall total rebate invoices totaled $90.8 million, and total rebate dollars collected so far
• > to<00:14:49.120> the Manufacturers pay rebates back to the Manufacturers pay rebates
• state, but individual drug rebate state, but individual drug rebate amounts<00:14:52.000> are
• rather than rebates is do cost plus. rather than rebates is do cost plus.

Keywords: 958, all

Summary: The Medicaid Oversight and Advisory Board met on February 23, 2026, approved the January 12 minutes, and then focused primarily on Kentucky Medicaid’s coverage and potential expansion of GLP-1 drugs, especially for weight loss. Department for Medicaid Services Commissioner Lisa Lee explained that Medicaid currently does not cover drugs for weight loss, anorexia, or weight gain, but the department had filed a regulation to remove that blanket exclusion so GLP-1s could be covered when used for an underlying health condition. She said the administrative regulation review subcommittee found the regulation deficient, and the co-chairs wanted the board to discuss the policy and financing implications before any change. DMS also said it would be open to adding caveats to ensure coverage would not extend to cosmetic weight loss alone. The department provided several data points on current utilization and spending. In 2025, Kentucky Medicaid paid for appetite-stimulating drugs such as Megestrol, Dronabinol, and Marinol, but did not pay for weight-loss drugs. For GLP-1s, DMS said coverage began in 2025 and is limited to FDA-approved medical conditions, with prior authorization requiring a type 2 diabetes diagnosis code and A1C documentation. DMS reported $234.6 million in GLP-1 spending in 2025 before rebates, about 240,931 prescriptions, and said GLP-1s accounted for 7.3% of pharmacy spend in 2024 and 8.3% in 2025. It also said there were 24,844 expansion members and 13,638 non-expansion members using GLP-1s, with spending of about $156 million and $78.5 million respectively, and that 10 pediatric weight-loss prescriptions were covered under EPSDT. The department said outcome analyses, including whether GLP-1 use reduces insulin or other diabetes treatment, are underway and should be completed in a couple of months. Members asked about cost, rebates, and whether the state should wait for more outcomes data before expanding coverage. DMS said average reimbursement to pharmacies was $975 per prescription and the average dispensing fee was $109; it also said 2025 rebate invoices totaled $90.8 million, with $7.6 million collected so far. Several members expressed concern about the high cost and the need to evaluate whether the drugs improve health outcomes before expanding access, while others noted the potential benefits for obesity and diabetes treatment. Some members also discussed whether GLP-1s are effectively being used for weight loss in diabetic patients and whether broader data collection should be used to assess long-term value. After the Medicaid discussion, Eli Lilly executive Tracy Sims presented on obesity as a chronic disease and the economic burden it creates in Kentucky. She said Kentucky’s adult obesity rate is a little over 37%, that obesity is linked to about 200 diseases, and that untreated obesity costs the state billions in GDP and hundreds of millions in state budget impact. She highlighted recent federal access programs for GLP-1s, including a Medicaid-related program that she said could lower the state share of a Zepbound prescription to about $71 per month after federal matching. No votes were taken on the GLP-1 policy question during the meeting, and the main action was the receipt of testimony and discussion of the department’s proposed regulatory change.